Overview
- Israel’s prime minister disclosed Friday that doctors found a very small malignant lesion during routine prostate follow-up and said targeted treatment cleared it.
- An official medical bulletin said he received radiotherapy for early-stage prostate cancer and is in good condition.
- Tests showed no metastasis, according to Netanyahu’s statement and the medical report.
- Neither his post nor the bulletin specified when the treatment took place.
- His office has previously confirmed prostate surgery in 2024 for benign enlargement and a urinary infection, and he received a pacemaker in 2023.